What Researchers Did
Chinese researchers systematically reviewed the biological mechanisms by which HBOT may protect the brain after cardiac arrest and successful resuscitation (CPR), focusing on how HBOT targets multiple injury pathways simultaneously.
What They Found
Survival after CPR globally is below 8%, with brain injury (hypoxic-ischemic brain injury, HIBI) causing death in 68% of survivors. The review identified four HBOT mechanisms for HIBI: blocking cell death, reducing oxidative damage, lowering brain inflammation, and improving blood-brain barrier function. Emerging combinations with gut microbiome modulation and active CPR techniques were identified as promising targets.
What This Means for Canadian Patients
For Canadians resuscitated after cardiac arrest, brain injury during the minutes without blood flow is the primary threat to survival and quality of recovery. This review synthesizes why HBOT could be a strong candidate for post-resuscitation brain protection, an application that could directly benefit Canadian cardiac arrest survivors in ICUs at major hospitals.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a narrative review and does not include a meta-analysis of clinical trial data; it reflects preclinical and early clinical evidence, not proven patient outcomes.